For purposes of this chapter, the following definitions shall apply unless the context clearly indicates or requires different meaning:
PRODUCT CONTAINING A SYNTHETIC ALTERNATIVE DRUG: Any product containing a synthetic cannabinoid, stimulant or psychedelic/hallucinogen, as those terms are defined herein such as, but not limited to, the examples of brand names or identifiers listed on exhibit A attached to the ordinance codified herein.
SYNTHETIC CANNABINOID: Any laboratory created compound that functions similar to the active ingredient in marijuana, tetrahydrocannabinol (THC), including, but not limited to, any quantity of a natural or synthetic material, compound, mixture, preparation, substance and their analog (including isomers, esters, ethers, salts, and salts of isomers) containing a cannabinoid receptor agonist, such as:
JWH-007 (1-pentyl-2-methyl-3-(1-naphthoyl)indole)
JWH-015 ((2-Methyl-1-propyl-1H-indol-3-yl)-1- naphthalenylmethanone)
JWH-018 (1-pentyl-3-(1-naphthoyl)indole)
JWH-019 (1-hexyl-3-(naphthalen-1-oyl)indole)
JWH-073 (naphthalen-1-yl-(1-butylindol-3- yl)methanone)
JWH-081 (4-methoxynaphthalen-1-yl-(1-pentylindol- 3-yl)methanone)
JWH-098 (4-methoxynaphthalen-1-yl-(1-pentyl-2- methylindol-3-yl)methanone)
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole)
JWH-164 (7-methoxynaphthalen-1-yl-(1-pentylindol- 3-yl)methanone
JWH-200 (1-(2-morpholin-4-ylethyl)indol-3-yl)- naphthalen-1-ylmethanone)
JWH-203 (2-(2-chlorophenyl)-1-(1-pentylindol-3- yl)ethanone
JWH-210 (4-ethylnaphthalen-1-yl-(1-pentylindol-3- yl)methanone
JWH-250 (1-pentyl-3-(2-methoxyphenylacetyl)indole)
JWH-251 (1-pentyl-3-(2-methylphenylacetyl)indole)
JWH-398 (1-pentyl-3-(4-chloro-1-naphthoyl)indole)
HU-210 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl- 3-(2-methyloctan-2-yl)-6a,7,10,10a- tetrahydrobenzo[c]chromen-1-ol)
HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl- 3-(2-methyloctan-2-yl)-6a,7,10,10a- tetrahydrobenzo[c]chromen-1-ol)
HU-308 ([(1R,2R,5R)-2-[2,6-dimethoxy-4-(2- methyloctan-2-yl)phenyl]-7,7-dimethyl-4- bicyclo[3.1.1]hept-3-enyl] methanol)
HU-331 ((3-hydroxy-2-[(1R,6R)-3-methyl-6-(1- methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5- cyclohexadiene-1,4-dione)
CP 55,940 (2-[(1R,2R,5R)-5-hydroxy-2-(3- hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2- yl)phenol)
CP 47,497 (2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2- methyloctan-2-yl)phenol) and its homologues
WIN 55,212-2 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4- morpholinylmethyl)pyrrolo[1,2,3-de)-1,4- benzoxazin-6-yl]-1-nepthalenylmethanone)
RCS-4 ((4-methoxyphenyl)(1-pentyl-1H-indol-3- yl)methanone)
RCS-8 (1-(1-(2-cyclohexylethyl)-1H-indol-3-yl)-2- (2-methoxyphenyl)ethanone)
SYNTHETIC PSYCHEDELIC/HALLUCINOGEN: Any compound that mimics the effects of any federally controlled schedule I substance, including, but not limited to, any quantity of a natural or synthetic material, compound, mixture, preparation, substance and their analog (including salts, isomers, esters, ethers and salts of isomers) containing substances which have a psychedelic/hallucinogenic effect on the central nervous system and/or brain, such as:
2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E);
2-(2,5-dimethoxy-4-methylphenyl)ethanamine (2C-D);
2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C);
2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I);
2-(4-(Ethylthio)-2,5-dimethoxyphenyl)ethanamine (2C-T-2);
2-(4-(Isopropylthio)-2,5- dimethoxyphenyl)ethanamine (2C-T-4);
2-(2,5-Dimethoxyphenyl)ethanamine (2C-H);
2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N);
2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P).
SYNTHETIC STIMULANT: Any compound that mimics the effects of any federally controlled schedule I substance such as cathinone, methcathinone, MDMA and MDEA, including, but not limited to, any quantity of a natural or synthetic material, compound, mixture, preparation, substance and their analog (including salts, isomers, and salts of isomers) containing substances which have a stimulant effect on the central nervous system, such as:
3-Fluoromethcathinone
4-Fluoromethcathinone (other name: flephedrone)
3,4-Methylenedioxymethcathinone (other name: methylone, MDMC)
3,4-Methylenedioxypyrovalerone (other name: MDPV)
4-Methylmethcathinon (other names: mephedrone, 4-MMC)
4-Methoxymethcathinone (other names: methedrone, bk-PMMA, PMMC)
4-Ethylmethcathinone (other name: 4-EMC)
Ethcathinone
Beta-keto-N-methylbenzodioxyolylpropylamine (other names: butylone, bk-MBDB)
Napthylpyrovalerone (other names: naphyrone, NRG-1)
N,N-dimethylcathinone (other name: metamfepramone)
Alpha-pyrrolidinopropiophenone (other name: alpha-PPP)
4-methoxy-alpha-pyrrolidinopropiophenone (other name: MOPPP)
3,4-methylenedioxy-alpha-pyrrolidinopropiophenone (other name: MDPPP)
Alpha-pyrrolidinovalerophenone (other name: alpha-PVP)
6,7-kihydro-5H-indeno(5,6-d)-1,3-dioxal-6-amine) (other name: MDAI)
Any compound that is structurally derived from 2- amino-1-phenyl-1-propanone by modification or substitution in any of the following ways:
In the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;
At the 3-position with an alkyl substituent;
At the nitrogen atom with alkyl, dialkyl, benzyl, or methoxybenzyl groups; or
By inclusion of the nitrogen atom in a cyclic structure. (Ord. 2075, 3-6-2012)